StonvexLoading…
StonvexStonvexStonvexCore line items from COF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.06B | $5.92B | $5.64B | $5.42B |
Operating Income | $2.28B | $5.91B | $6.04B | $9.24B |
Net Income | $2.45B | $4.75B | $4.89B | $7.36B |
EPS (Diluted) | $4.03 | $11.59 | $11.95 | $17.91 |
Total Assets | $669.01B | $490.14B | $478.46B | $455.25B |
Total Liabilities | $555.39B | $429.36B | $420.38B | $402.67B |
Cash & Equivalents | $62.09B | $43.67B | $43.76B | $31.26B |
Free Cash Flow OCF − CapEx | $26.14B | $16.95B | $19.61B | $12.88B |
Shares Outstanding | 625.10M | 381.23M | 380.39M | 381.32M |